Patent · US Active

Tetracyclic lactame derivatives

US7838674B2 · kind B2 · utility

14Cited by

0References

12Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Achim Schlapbach · Bad Kötzting, DE
Laszlo Revesz · Therwil, CH
Guido Koch · Karlsruhe, DE

Key dates

Filing date	Jul 16, 2008
Grant date	Nov 23, 2010
Priority date	—
Expiry date	Feb 12, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention describes tetracyclic compounds of formula (IA) or (IB),wherein the symbols R, X, A, Y, R2, R3 and D are as defined in the specification, their use in the treatment of certain diseases, e.g. depending on MK-2 or TNF activity, and ways of manufacturing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.